| Cell line name |
D18 |
|---|
| Accession |
CVCL_B4KG |
|---|
| Resource Identification Initiative |
To cite this cell line use: D18 (RRID:CVCL_B4KG) |
|---|
| Sequence variations |
- Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=22383533).
- Mutation; HGNC; HGNC:9612; PTK2B; Simple; p.Gly414Val (c.1241G>T); Zygosity=Heterozygous (PubMed=22383533).
|
|---|
| Disease |
Melanoma (NCIt: C3224) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Sex of cell |
Sex unspecified |
|---|
| Age at sampling |
Age unspecified |
|---|
| Category |
Cancer cell line |
|---|
| Publications | PubMed=22383533; DOI=10.1158/1535-7163.MCT-11-0676
Ken Dutton-Regester, Darryl Irwin, Priscilla Hunt, Lauren G. Aoude, Varsha Tembe, Gulietta M. Pupo, Cathy Lanagan, Candace D. Carter, Linda O'Connor, Michael O'Rourke, Richard Anthony Scolyer ...Show all 15 authors... , Graham J. Mann, Christopher W. Schmidt, Adrian Herington, Nicholas K. Hayward; Show fewer authors
A high-throughput panel for identifying clinically relevant mutation profiles in melanoma.
Mol. Cancer Ther. 11:888-897(2012) |
|---|
| Cross-references |
|---|
| Cell line databases/resources |
cancercelllines; CVCL_B4KG
|
|---|
| Encyclopedic resources |
Wikidata; Q110432764
|
|---|
| Entry history |
|---|
| Entry creation | 16-Dec-2021 |
|---|
| Last entry update | 19-Dec-2024 |
|---|
| Version number | 5 |
|---|
